American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Perales
    Perales
  5. Tallman
    Tallman
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Palomba
    Palomba
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (4000)
  2. Hematologic Malignancies, Division of (3803)
  3. Center for Hematologic Malignancies (3680)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1343)
  6. Sloan Kettering Institute Faculty (1075)
  7. Bone Marrow Transplant (988)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (955)
  9. Lymphoma (941)
  10. Tow Center for Developmental Oncology (TCDO) (882)
Search Within
Formats
  1. Meeting Abstract (4150)
  2. Journal Article (1257)
  3. Research Letter (46)
  4. Review (44)
  5. Editorial (35)
  6. Guidelines (13)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (4000)
  2. Hematologic Malignancies, Division of (3803)
  3. Center for Hematologic Malignancies (3680)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1343)
  6. Sloan Kettering Institute Faculty (1075)

More Groups

People
  1. Sergio Giralt (348)
  2. Andrew Zelenetz (341)
  3. Ross Levine (316)
  4. Miguel-Angel Perales (312)
  5. Martin Tallman (301)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (64)
  2. 2024 (428)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (5174)
  2. Blood Advances (331)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5555)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Endothelial cells promote endogenous thymic regeneration after injury via BMP4 signaling
    Meeting Abstract

    Wertheimer, T.; Kloss, C. C.; Velardi, E.; Brede, C.; Ginsberg, M.; Kreines, F. M.; Zakrzewski, J. L.; Tuckett, A. Z.; Tsai, J. J. Y.; Smith, O. M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Interim analysis of a randomized phase II trial comparing continuous lenalidomide and dexamethasone to autologous stem cell transplantation in multiple myeloma patients responsive to lenalidomide and dexamethasone induction
    Meeting Abstract

    Weltz, J. I.; Landau, H.; Lendvai, N.; Chung, D. J.; Lesokhin, A. M.; Devlin, S. M.; Riedel, E.; Woo, K. M.; Stellman, A.; Chimento, D.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Telomere length is associated with specific mutations and mutation classes in patients with acute myeloid leukemia
    Meeting Abstract

    Watts, J. M.; Dumitriu, B.; Hilden, P.; Chen, C.; Rapaport, F.; Kishtagari, A.; Ahn, J.; Devlin, S. M.; Rampal, R. K.; Levine, R. L.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Effect of genetic profiling on prediction of therapeutic resistance and survival in adult acute myeloid leukemia
    Meeting Abstract

    Walter, R. B.; Othus, M.; Paietta, E. M.; Racevskis, J.; Fernandez, H. F.; Lee, J. W.; Sun, Z. X.; Tallman, M. S.; Patel, J. P.; Gonen, M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • High frequency of identical lymphoma clones detected in pre-treatment tumor and plasma from untreated patients with HIV-associated lymphomas: Prospective multicenter trial of the AIDS Malignancy Consortium (AMC 064)
    Meeting Abstract

    Wagner-Johnston, N.; Lee, J. Y.; Silver, S.; Noy, A.; Mims, M. P.; Pepin, F.; Moorhead, M.; Faham, M.; Ambinder, R. F.
    Blood (2014)

    Fulltext@MSK | Save
  • Splenic irradiation and a reduced-intensity conditioning regimen prior to allogeneic stem-cell transplantation for myelofibrosis
    Meeting Abstract

    Vyas, O. H.; Kaul, E.; Rosenberg, A. S.; Shah, G. L.; Shah, U. A.; Comenzo, R. L.; Kao, G. S. H.; Evens, A. M.; Smith, H.; Klein, A. K.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Phase 1/2 study in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia (BCP-ALL) receiving blinatumomab treatment
    Meeting Abstract

    Von Stackelberg, A.; Locatelli, F.; Zugmaier, G.; Handgretinger, R.; Trippett, T. M.; Rizzari, C.; Zwaan, C. M.; Bhojwani, D.; DuBois, S. G.; Bader, P.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Ibrutinib, single agent or in combination with dexamethasone, in patients with relapsed or relapsed/refractory multiple myeloma (MM): Preliminary phase 2 results
    Meeting Abstract

    Vij, R.; Huff, C. A.; Bensinger, W. I.; Siegel, D. S.; Jagannath, S.; Berdeja, J.; Lendvai, N.; Lebovic, D.; Anderson, L. D.; Costello, C. L.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Ofatumumab versus rituximab salvage chemoimmunotherapy in relapsed or refractory diffuse large B-cell lymphoma: The Orcharrd Study (OMB110928)
    Meeting Abstract

    van Imhoff, G. W.; McMillan, A.; Matasar, M. J.; Radford, J.; Ardeshna, K. M.; Kuliczkowski, K.; Kim, W.; Hong, X. N.; Goerloev, J. S.; Davies, A.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Plasma protease-mediated metabolism of carfilzomib and its implications on clinical effects and side effects
    Meeting Abstract

    Tristan, S. M.; Peer, C. J.; Korde, N.; Nehal, L.; Sham, M.; Landgren, O.; Figg, W. D.
    Blood (2014)

    Fulltext@MSK | Save